Enochian BioSciences to Present to Investors at 22nd Annual H.C. Wainwright Global Investment Conference
Read More About it Here
One audacious mission to use groundbreaking science for cures and effective prevention of infectious diseases and cancer.Read More About our Mission
Enochian BioSciences is a biopharmaceutical company dedicated to identifying, developing, manufacturing, and commercializing gene-modified cell therapy. Our gene-modified cell therapy platform can be applied to multiple indications including HIV/AIDS and Oncology.
Focused for the prevention of relapse of metastatic colon cancer after resection and chemotherapy